Literature DB >> 8622040

Predicting the risk of bacteremia in childen with fever and neutropenia.

W R Rackoff1, R Gonin, C Robinson, S G Kreissman, P B Breitfeld.   

Abstract

PURPOSE: We sought to identify factors assessable at the time of admission for fever and neutropenia that predict bacteremia in children with cancer. PATIENTS AND METHODS: One hundred fifteen consecutive episodes of fever and absolute neutrophil count (ANC) less than 500/microliter in 72 children with cancer were studied prospectively to determine the risk of bacteremia using data assessable at the time of presentation. After exploratory analysis identified admission temperature and absolute monocyte count (AMoC) as the strongest predictive factors, recursive partitioning was used to determine cutpoints for these variables that resulted in discrimination between episodes associated with a lower or higher risk of bacteremia.
RESULTS: There were 24 episodes of bacteremia (21% of episodes). Episodes were grouped using the cutpoints for AMoC and temperature: 17% were classified as low risk for bacteremia (AMoC > or = 100/microliter), 65% as intermediate risk (AMoC < 100/microliter and temperature < 39.0 degrees C), and 18% as high risk (AMoC < 100/microliter and temperature > or = 39.0 degrees C). No episodes classified as low risk were associated with bacteremia; 19% of intermediate-risk and 48% of high-risk episodes were associated with bacteremia. The odds ratio of bacteremia for the high-risk versus the intermediate-risk group is 4.4 (95% confidence interval, 1.6 to 12.9). The risk classification was validated using data from 57 different episodes of fever and neutropenia treated in the same hospital.
CONCLUSION: Three levels of risk for bacteremia are defined using the AMoC and temperature at the time of admission for fever and neutropenia. Trials now should be conducted to test whether these factors may be used to assign some children to less intensive or outpatient antibiotic therapy at the time of presentation with fever and neutropenia.

Entities:  

Mesh:

Year:  1996        PMID: 8622040     DOI: 10.1200/JCO.1996.14.3.919

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  32 in total

Review 1.  Updated review of blood culture contamination.

Authors:  Keri K Hall; Jason A Lyman
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 2.  Outpatient therapy for febrile neutropenia: clinical and economic implications.

Authors:  Fausto de Lalla
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

3.  Can complications in febrile neutropenia be predicted? Report from a developing country.

Authors:  Sapna Oberoi; Anirban Das; Amita Trehan; Pallab Ray; Deepak Bansal
Journal:  Support Care Cancer       Date:  2017-06-11       Impact factor: 3.603

Review 4.  Outpatient management of febrile neutropenia in children with cancer.

Authors:  Mark Holdsworth; Jeff Hanrahan; Bernadette Albanese; Jami Frost
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

5.  Fever in neutropenia in children and adolescents: evolution over time of main characteristics in a single center, 1993-2001.

Authors:  Roland A Ammann; Christoph Aebi; Andreas Hirt; Annette Ridolfi Lüthy
Journal:  Support Care Cancer       Date:  2004-07-08       Impact factor: 3.603

6.  Repeating blood cultures in neutropenic children with persistent fevers when the initial blood culture is negative.

Authors:  Jeremy Rosenblum; Juan Lin; Mimi Kim; Adam S Levy
Journal:  Pediatr Blood Cancer       Date:  2012-10-09       Impact factor: 3.167

Review 7.  Hyperpyrexia and high fever as a predictor for serious bacterial infection (SBI) in children-a systematic review.

Authors:  Noa Rosenfeld-Yehoshua; Shiri Barkan; Ibrahim Abu-Kishk; Meirav Booch; Ruth Suhami; Eran Kozer
Journal:  Eur J Pediatr       Date:  2018-01-31       Impact factor: 3.183

8.  Evaluation of a fever-management algorithm in a pediatric cancer center in a low-resource setting.

Authors:  Sheena Mukkada; Cristel Kate Smith; Delta Aguilar; April Sykes; Li Tang; Mae Dolendo; Miguela A Caniza
Journal:  Pediatr Blood Cancer       Date:  2017-09-12       Impact factor: 3.167

9.  Developing a national 'low risk' febrile neutropenia framework for use in children and young people's cancer care.

Authors:  F Gibson; J Chisholm; E Blandford; P Donachie; J Hartley; S Lane; K Selwood; R Skinner; R Phillips
Journal:  Support Care Cancer       Date:  2012-12-20       Impact factor: 3.603

10.  Predicting the complicated neutropenic fever in the emergency department.

Authors:  J M Moon; B J Chun
Journal:  Emerg Med J       Date:  2009-11       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.